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Leprosy provides a useful model for understanding immunoregulatory mecha-
nisms in man. The disease forms a spectrum in which the immunologic response
ofthe patient correlates with the clinical and histopathologic classification (1-3). At
one end ofthe spectrum, patients with tuberculoid leprosyhave one or several skin
lesions in which bacilli can rarely be identified. CD4+ T lymphocytes predominate
in these lesions (4-7) and respond to Mycobacterium leßrae in vitro (8). At the other
end of the spectrum, patients with lepromatous leprosy have diffuse infiltration of
skin and nerves with bacilli-laden macrophages. CD8+ cells predominate in
lepromatous lesions and function as antigen-specific Ts cells in vitro (9, 10). The
CD4+ lymphocytes derived from these lesions are unresponsive to M. leßrae. Im-
posed upon this spectrum are the so-called "reactional states" of reversal reaction
and erythema nodosum leprosum (ENL)' that are of immunologic interest in un-
derstanding mechanisms of immunoregulation in man.
The reversal reaction syndrome is associated with a marked rise in lymphocyte
transformation to M. leßrae antigens invitro, and is therefore thoughtto beadelayed-
type hypersensitivity (DTH) reaction against M. leßrae antigens (11-15). Clinically,
the condition is often associated with reduction or elimination of bacilli in lesions
and sometimes followed by upgrading of the clinical and histological classification
toward the tuberculoid pole. The pathogenesis ofENL reactions issomewhat contro-
versial, thought to be due toimmune complex deposition in thelesions (16-18)and/or
increases in cell-mediated immunity (19, 20).
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Immunohistologic study of skin lesions has thus far not distinguished between
the immune processes underlying the pathogenesis of reversal reaction and ENL
(21-25) . The inflammatory infiltrates in both reactional states are characterized by
a predominance of CD4' lymphocytes. IL-2-containing cells are present in the le-
sions of both conditions. Furthermore, keratinocyte la expression, a putative marker
ofIFN-y production, and Langerhans cell hyperplasia are apparent in the epidermis
overlying both reactional states.
The present study was undertaken to investigate the immunoregulatory processes
that underlie these reactional states of leprosy, utilizing newly developed reagents
and technology to analyze the inflammatory infiltrates. We performed in situ hy-
bridization to cellular mRNA using probes for IFN-y and human serine esterase
(huHF), a marker for cytotoxic cells, in order to define functional T cell subpopula-
tions in these reactions. The findings of these studies were then analyzed in the con-
text of immunostaining of lesions with mAbs that define subpopulations of CD4'
and CD8' lymphocytes. The results suggest that reversal reactions are more char-
acteristic of classical DTH reactions than ENL, and represent a window into the
complex immunoregulatory mechanisms underlying the pathogenesis ofDTH in man.
Materials and Methods
Patients.
￿
Patients with leprosy were classified according to the clinicopathological criteria
of Ridley and Jopling (1). Clinical criteria for the diagnosis of reversal reactions included
torpid lesions becoming erythematous and tumid, the abrupt onset of new erythematous,
tumid lesions, and the sudden onset of neuritis. Histological changes were not uniform but
included edema in the granulomas, increased numbers of lymphocytes, giant cells, and des-
moplasia of the connective tissue. The diagnosis of ENL was made using clinical and histo-
pathologic criteria. Patients presented with the distinctive picture ofcrops ofpainful and tender
erythematous nodules in association with fever, malaise and arthralgias. Histopathologic ex-
amination of lesions revealed the presence of neutrophils and lymphocytes superimposed over
a lepromatous infiltrate. In addition, lepromin skin tests (3-wk Mitsudareactions) were studied
from tuberculoid patients (26). All specimens were obtained with informed consent from
tuberculoid patients (26). All specimens were obtained with informed consent from patients
at the Outpatient Clinic of Los Angeles County/University of Southern California Medical
Center, San Francisco Medical Center (with gratitude to Dr. Robert Gelber), and McKean
Reliability Institute, Chiang Mai, Thailand. The patients were distributed among the different
diagnostic groups showing no segregation according to sex, race, or age.
Tissues.
￿
Skin biopsy specimens, obtained by punch or scalpel technique, were divided
for histological diagnosis on conventional paraffin sections and for immunoperoxidase and
in situ hybridization study by snap freezing in liquid nitrogen tissue embedded in OCT medium
(Ames Co., Elkhart, .IN). The tissues were stored at -70'C until sectioning.
In Situ Hybridization
The in situ hybridization technique described below was performed as previously described
(27).
Tissue Preparation.
￿
Biopsy specimens were collected and frozen as described above. 3-Am
cryostat sections were placed on poly-L-lysine hydrobromide-coated slides (Sigma Chemical
Co., St. Louis, MO) and air dried for 2 h. Dried sections were fixed for,20 min in 4%
paraformaldehyde-PBS (pH 7 .4), rinsed through several changes ofPBS (Flow Laboratories,
Inc., McLean, VA), and dehydrated through graded alcohols. Sections were stored dessicated
at 4°C until use.
Probe Preparation.
￿
Two probes were utilized in the present study: IFN-y cDNA, which was
provided by Hoffmann-La Roche, Inc. (Nutley, NJ), and huHF gene coding forhuman serine
esterase, as described previously (28). The cDNA was recloned into an expression vector systemCOOPER ET AL.
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that would allow for the generation of both sense as well as antisense "S-labeled RNA probes.
IFN-,y cDNA was inserted into pGem-1 (Promega Biotec, Madison, WI) and the huHF gene
into a pGem-1 like vector, pSPT671 (27). Template DNA was prepared in each case by
linearizing plasmid DNA with restriction enzymes that cut once at the distal end ofthe cloned
insert; this restricted in vitro RNA synthesis to probe-specific sequences. Both inserts were
cloned in the 5' to 3' direction so that RNA transcripts generated in vitro by transcription
from the 5' SP6 promotor-generated sense-strand RNA, while the 3' T7-directed synthesis
produced antisense RNA. 35S-labeled transcripts were reduced to an average 200-bp length
by alkaline hydrolysis (29), then ethanol precipitated after adding 7 .5 Ftg yeast tRNA/106
cpm. The probe was subsequently resuspended at 1-2 x 106 cpm in 10 mM Tris with 1 mM
EDTA, pH 8, and stored at -70°C until hybridization to tissue sections.
Hybridization.
￿
Sections were digested in 1 ug/ml proteinase K in 100 mM Tris/50 mM
EDTA, pH 8, at 37'C for 30 min, then refixed for 20 min in 4% paraformaldehyde/PBS
to stabilize cellular mRNA within the proteolyzed matrix. Free amino groups on tissue sec-
tions were acetylated by treatment with 0.25% acetic anhydride in 0.1 M triethanolamine
(pH 8) for 10 min; the tissues were rinsed briefly in water then air dried while awaiting hy-
bridization. For hybridization, probe (denatured at 80'C for 3 min) was mixed with forma-
mide (50% finalconcentration), NaCl (300 mM), Tris-HCl, pH 7.5 (20 mM), EDTA (5 mM),
Denhardt'ssolution (1 x), dextran sulfate (10%), and dithiotreitol (100 mM) at a final concen-
tration of 105 cpm/p.l hybridization mix. 10,ul of this hybridization solution containing 106
cpm probe was added to each slide, the tissue covered with a siliconized coverslip, and sealed
with rubber cement. Slides were hybridized for 17-20 h at 47°C . Unhybridized probe was
washed from the slides in a solution of 50% formamide, 2 x SSC, and 5 mM EDTA in four
changes for a totalof2 h at 56°C. After the second wash, the slides were digested with RNase
A (20 jig/ml) and RNase TI (1 U/ml) for 30 min at 37°C. After the last wash, slides were
dehydrated through graded alcohols containing 400 mM ammonium acetate and air dried.
For autoradiography, slides were dipped into Kodak NTB-2 emulsion, diluted 1 :2 with 400
mM ammonium acetate, and exposed at 4'C for 10-28 d. The slides were then developed
using Dektol developer (1 :2 in water) for 2 min and Fixer for 5 min (photography supplies
from Eastman Kodak; Rochester, NY) and counterstained with eitherhematoxlyin and eosin
(IFN-y) or 4% Giemsa (huHF). Each tissue was hybridized with sense-strand (homologous
to cellular mRNA) as well as antisense strand (complementary to cellular mRNA) probes;
known positive and negative control tissues were included in each run.
Evaluation ofSlides.
￿
Cells were considered to be positive for the expression of IFN-,y when
they contained greater than twice the number of grains ofthe most positive cell on the control
(sense) slide for the same tissue. Positive cells were enumerated over the entire tissue section
and the percentage of positive cells was then calculated (8). Cells positive for huHF were
numerous and were estimated by three independent observers whose percentages were within
five percentage points. Gene expression levels were evaluated by determining the median
grain number over background of positive cells in each section.
Immunostaining Studies
mAbs.
￿
Primary mouse anti-human lymphocyte mAbs were used at optimal concentra-
tions (CD3, pan T cell marker, anti-Leu-4 at 1 :200; CD8, T suppressor/cytotoxic marker,
anti-Leu-2a at 1 :50; CD4, T helper/inducer marker anti-Leu-3a at 1 :50 [all from Becton
Dickinson & Co., Mountain View, CA]) as determined by checkerboard titration on cells
from reactive tonsils.
Recently, these CD4 and CD8 subsets have been further divided into subpopulations by
new mAbs (30). CD8' cells that bear the 9.3 marker (CD28) have cytotoxic function, and
cells that are CD8' 9.3- have suppressor function in vitro (31). Similarly, evidence suggests
that CD4' cells bearing the 4114 (CDw29) or UCHLI (CD45) markers belong to a T
helper/memory subpopulation (32, 33) whereas those expressing 2114 (CD45R) or Leu-8
antigens comprise a population ofnaive T cells(34-36). Anti-2114 was used at 1:50, anti-4134
at 1 :400 (both from Coulter Electronics Inc., Hialeah, FL), UCHL1 (Dr. P Beverley, London)
at 1 :20, anti-Leu-8 at 1 :100 (Becton Dickinson & Co.), and anti-9.3 (Dr. J. Hansen, Seattle,
WA) was used at 1 :50. Controls in each experiment included omission of the primary anti-1568
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body and the use of irrelevant antibodies of the same IgG subclass on sections for the same
period of incubation. Blocking was used for some mAbs that gave significant levels of back-
ground staining, (e.g., anti-4B4, -9.3, and -Leu-3a). Where appropriate, slides were prein-
cubated in normal serum (1 :20 in PBS) derived from the species that generated the secondary
antibody; i.e., normal goat serum was used when the linking antibody was biotinylated goat
antimouse.
Single Immunoperoxidase Staining.
￿
All sections were acetone fixed and incubated sequen-
tially as described (21): first with the mAbs, then peroxidase-conjugated goat anti-mouse IgG
1 :20 (Tago Inc., Burlingame, CA) for 30 min with 10-min PBS washes between each incuba-
tion. Slides were then incubated with the chromogen aminoethyl carbazole (AEC) in the pres-
ence of hydrogen peroxide for 15 min, counterstained with hematoxylin, and then mounted
in glycerine-gelatin. The IFN--y-induced peptide, IP-10, was visualized in tissue sections using
a rabbit polyclonal antibody as previously reported (37).
Double Immunoperoxidase Staining.
￿
This procedure allows for the visualization of two an-
tigens on the same section. For the monoclonals that gave significant levels of background
staining, the sections were first blocked with normal goat or horse serum (diluted 1 :20 in
PBS), as specified above. Each section was stained first with primary mAbs followed by goat
anti-mouse IgG-peroxidase conjugate. Throughout both single and double immunostaining
procedures, each antiserum (or Avidin-Biotin complex) was applied to the tissue section for
30 min, followed by a 10-min PBS wash. The first reaction was developed by a short (8-min)
incubation in AEC. The development period was shorter than that used in single staining
so that the strong AEC precipitate would not obscure the weaker blue precipitate deposited
in the second stage of the procedure. The sections were washed with PBS for 10 min. Before
the second stain, all sections were blocked with normal horse serum at 1 :20 (Vector Labora-
tories, Inc., Burlingame, CA). Subsequently, the slides were incubated with the second pri-
mary antibody, washed and then incubated with the secondary biotinylated horse anti-mouse
IgG 1 :50 (Vector Laboratories, Inc.), followed by an incubation with the ABC-GO kit (Vector
Laboratories, Inc.). The blue color was developed with a glucose oxidase substrate kit (con-
taining nitroblue tetrazolium as chromogen) or alternatively using /3-galactosidase kit (Vector
Laboratories, Inc.) using X-gal as the chromogenic substrate. Slides were then rinsed in tap
water for 10 min and mounted with glycerine-gelatin. Control slides, on which either of the
primary antisera were omitted, demonstrated that the second labeling system did not cross-
react with the antibodies already added in the first reaction.
Quantitation ofStained Cells.
￿
Single staining cells were numerous, such that the percentage
of positive cells was determined by averaging the estimates of two independent observers;
their reading invariably agreed within five percentage points. For double immunostaining,
cells were counted to be double positive when both red and blue colors could be seen on
the same cells or a purple color distinct from either red- or blue-colored cells in the same
section was identified. Percentages of double-stained cells were determined as described pre-
viously (38).
Results
IFN-y Gene Expression in Lesions.
￿
To assess functional activity of T lymphocytes
in lesions, we initially performed in situ hybridization to detect IFN-1' mRNA. 16 pa-
tients with reversal reaction were studied, all ofwhom were classified as having border-
line lepromatous leprosy. 10 patients with ENL were classified as having leproma-
tous disease. Findings were compared with specimens from patients with borderline
lepromatous leprosy not in reversal reaction (n = 7), tuberculoid patients (n = 15),
and lepromatous patients (n = 10). Since the "Mitsuda" reaction to M. leprae is an
established measure ofDTH, skin test reactions in three responsive individuals were
studied . Cells showing positive hybridization were most numerous in reversal reac-
tions, followed by lepromin skin tests and tuberculoid lesions (Figs. 1 and 2). In
comparison, lesions from nonreactional lepromatous patients and patients with ENLCOOPER ET AL.
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contained few positive cells, generally an orderofmagnitude lower than in reversal
reactions. The positive cells were centrally located within the granuloma in reversal
reactions andtuberculoidlesions, suggestingthat they are oftheTh phenotype(Fig. 1).
Therelative level ofmRNAwasestimatedby determination ofthe number ofgrains
per average positive cell. IFN-y mRNA expression was five times higher in reversal
reactions than tuberculoid lesions or lepromin skin tests (Fig. 2). Interestingly, the
few positive cells in ENL lesions contained levels of IFN-y mRNA that were five
times greater than found in lepromatous cases.
To obtain evidence that IFN-y mRNA wastranslated intofunctional protein, im-
munostaining for IP-10 was undertaken. This peptide has been reported to be
specifically induced by IFN-y in cells, including keratinocytes (37). The majority
ofkerotinocytesoverlyingreversal reactions and tuberculoidleprosy stained positive
for IP-10 (Fig. 1), indicating the presence of IFN-y in these lesions. On the other
hand, few keratinocytes in lepromatous epidermis were positive for IP-10. ENL le-
sions gave an intermediate staining pattern.
huHF Gene Expression in Lesions.
￿
We investigated lesions forthe presenceofTcells
of cytotoxic function using a riboprobe for the enzymatic marker associated with
cytotoxic cells, serine esterase (huHF). Cells positive forhuHF were more numerous
in tuberculoid, lepromin skin tests, and reversal reaction lesions, as compared with
ENL and nonreactional lepromatous lesions (Figs. 3 and 4). The microanatomic
location ofhuHF+ cells within granulomas oftuberculoid leprosy and reversal reac-
tion was similar to that ofthe CD4+UCHL1' subpopulation (see Fig. 3). The rela-
tive gene expression washigher inreversal reactionthan in tuberculoid lesions (Fig. 4).
T Cell Subsets in Lesions.
￿
The nature of the T lymphocyte infiltrates in lesions
ofleprosy reactional states was established by using mAbs in conjunction with im-
munohistochemical techniques. These studies were undertaken to provide ex-
perimental support for the in situ hybridization studies.
The distribution and location ofthe CD4 and CD8 T lymphocytes subsets were
found to be similarto that described in earlier studies (21, 22). CD4+ cells predomi-
nated in reversal reaction and ENL lesions, lepromin skin tests, and tuberculoid
lesions, but not in nonreactional borderline lepromatous or lepromatous lesions.
The pattern of cell distribution in reversal reaction specimens was similar to that
found in tuberculoid granulomas: CD4+ cells were distributed throughout the
granulomas with CD8+ cells confined to the surrounding mantle zone. In contrast,
in ENL and nonreactional lepromatous or borderline lepromatous lesions, both
CD4' and CD8+ cells were admixed throughout the biopsy sections.
CD4+ Subpopulations.
￿
To analyze in more detail the nature of the immunologic
processes underlying the reactional states, lesions were analyzed with mAbs used
to define subpopulations ofCD4 and CD8 cells. In reversal reactions, as in tuber-
culoid granulomas and Mitsuda reactions, 2H4' and Leu-8' cells were invariably
restricted to the mantle areasurrounding the granuloma, whereasthe cells associated
with macrophages in the granuloma were ofthe UCHL1 and 4134phenotype (Fig. 3).
These markers have been associated with differentiated or memory T cells and Th
cells. In contrast, in ENL and nonreactional lepromatous and borderline leproma-
tous, all phenotypes were admixed with macrophages.
Double immunostaining wasundertaken to quantify thevarious CD4 subpopula-
tions since somemarkers, such as UCHL1, are present on differentcell types (Fig. 5).1570
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FIGURE 1 .
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￿
In situ hybridization for IFN--y cellularmRNA in leprosylesions. (A)IFN- ,ymRNA-
positive cells can be identified by clustering of silver grains above cells in this reversal reaction
lesion (x 10 objective) . (B) Reversal reaction, higher power of(A) demonstrating positive cells
(x 25) . (C) ENL lesions with a single positive cell (x 25) . Control sections for reversal reaction
(D) and ENL (E) hybridized with sense probe show no hybridization (x 25). (F) Expression
of the IFN-,y inducible peptide, IP-10, by keratinocytes overlying reversal reaction lesions is evi-
dence that the IFN-,y mRNA is translated into functional protein (immunoperoxidase x 40) .1572
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FIGURE 2.
￿
IFN-.y mRNA in leprosy lesions
by in situ hybridization. (A) Percent of posi-
tive cells in lesions. (B) Gene expression as
measured by median grain count over back-
ground in positive cells.
In the more immunologically active forms ofleprosy, the ratio ofT helper/memory
(CD4+2H4-UCHLI') to T naive (CD4+2H4+) cells were high; however, the con-
verse was true for immunologically unresponsive forms ofleprosy. The memory to
naive ratio was 9:1 in reversal reaction, 6:1 for ENL, 13:1 forlepromin skin tests,
14:1 for tuberculoid lesions, and 1:1 for nonreactional patients with borderline
lepromatousorlepromatous disease. Double immunostaining withUCHL1 and Leu-8
gave results that were consistent with 2H4 results. CD4+UCHL1+ (T helper or
memory) cells were numerous in reversal reactions, ENL, and tuberculoid leprosy;
whereas, CD4+Leu-8+ (putative Ts-inducer) cells were a significant component of
the CD4 response in lepromatous individuals.COOPER ET AL.
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CD8+ Subpopulations.
￿
Antibody 9.3 was used in conjunction with Leu-2a (anti-
CD8) to divide CD8+ cells into two subphenotypes, Ts (9.3-) and T cytotoxic (9.3+)
cells (31). Double immunostaining revealed that cells of the T cytotoxic phenotype
were the predominant CD8+ subset in reversal reactions, lepromin skin tests, and
in tuberculoid lesions, while cells ofthe Ts phenotype were thepredominant CD8+
subset in nonreactional lepromatous and ENL lesions (Fig. 5). However, since the
numbers ofCD8+ cells in ENL lesions are few, the actual percentage of Ts pheno-
types in ENL lesions are far fewer than in nonreactional lepromatous lesions, on
the order ofthat in tuberculoid lesions.
Discussion
Analysis oftissue lesions ofthe major reactional states ofleprosy was undertaken
to studythe immunemechanismsunderlying regulationofcell-mediatedimmunity
and DTH in man. Study of the reactional states ofleprosy provides new insights
into these immune processes. Reversal reactions in leprosy are characterized by a
reduction, or occasionally theelimination, oforganisms from lesionswithupgrading
ofthe clinical classification, associated with a sudden gain in cell-mediated immu-
nity againstM. leprae in vitro. Cells infiltrating the reversal reaction lesions contained
mRNA coding for IFN-y, as well as human serine esterase, and expressed cell sur-
face antigenic determinants oftheTh andT cytotoxic subpopulations. These results
provide in vivoevidence that reversal reactions represent anaturallyoccurringDTH
reaction in leprosy. In contrast, the study of ENL lesions provides evidence sug-
gesting that this reactional state represents a transient cell-mediated immune pro-
cess clearly differentiated from the classical DTH response occurring in reversal
reaction.
In situ analysisoftissue lesions revealed greaternumbersofcellsexpressing IFN-y
mRNA, as well as cells of the T helper/memory phenotype (CD4+UCHLI +), in
reversal reactions, tuberculoid leprosy, and lepromin skin tests in comparison with
lepromatous leprosy. Such Th cells derived from leprosy lesions may contribute to
DTH by proliferating and producing IFN-y in response to M. leprae in vitro (38).
IFN-y is likely to be involved in the reduced numbers ofbacilli observed in reversal
reactions since this lymphokine has been shown to facilitate the intracellular killing
of mycobacteria in vitro and in vivo (39, 40).
Cells expressing serine esterasemRNA (huHF), a marker for cytotoxic cells, were
more abundant in reversal reactions, lepromin skin tests, and tuberculoid lesions
than in nonreactional lepromatous leprosy, and correlated in number with the
CD8+9.3+ T cytotoxic population. However, the microanatomic location of these
huHF+ cells throughout the granuloma indicate that some are likely to be either
macrophages or CD4+ cells. Since macrophages do not appear to express this gene
(41) and CD4 killers can release this protease (42), it appears that CD4+ cells in
reversal reaction lesionscontain this cytotoxic marker. Although NK cells have been
shown to produce serine esterase, immunohistologic analysis ofleprosy lesions has
failed to demonstrate the presence of cells bearing NK phenotypes. We have not
yet obtained functional evidence that cells in lesions have cytotoxic activity, and in
fact, Th cells have been shown to express the huHF marker (43); however, EM has
shown that cytolysis ofparasitized macrophages occurs within leprosy lesions (44).1574
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￿
In situ hybridization to detect serine esterase (huHF), amarker forT cytotoxic cells .
(A) Positive cells in this darkfield micrograph of a reversal reaction granuloma are identified by -
the clustering of white dots into spotsandare distributed throughout the granuloma in thesame
distribution of CD4' cells (x 25) . (B)A clustering of positive cells is observed in the ENL granu-
loma (x 40) . The sense control hybridizations are negative in both reversal reaction (E) and
ENL (F) (x 25) . Immunoperoxidase staining of reversal reaction granulomas revealed that
UCHLI' cells (C) are distributed throughout the granuloma ; whereas, 2H4' cells (D) are in
the lymphocytic mantle surrounding the granuloma (x 40) .1576
￿
IN SITU ANALYSIS OF LEPROSY LESIONS
A 30
z
O
W W J
N J
WW U
w
O
w
U
W a
B
J J W
U
w
F
N
O a
i
2
Q
C7
w
c7 Q
W
Q
20
10
60
50
40
30
20
10
FIGURE 4.
￿
Serine esterase (huHF) mRNA in
leprosy lesions by in situ hybridization. (A)
Percent of positive cells in lesions. (B) Gene
expression as measured by median graincount
over background in positive cells.
In addition, CD4+ antigen-specific killers have been isolated from the peripheral
blood ofleprosy patients (45). These T cytotoxic cells are thought to contribute to
hostdefenses against mycobacterial infection bylysing infected targets invitro(46). The
lysis ofthese infected targets in tuberculoid lesions may then eventuate in the elimi-
nation ofbacilli, allowing thedilution oforganisms from heavily parasitized macro-
phages intofreshIFN-y activatedphagocytes, where destruction can then take place.
Thedata presented demonstrate that reversal reactions are a naturally occurring
DTH reactionwithin leprosy. Although elimination ofreduction ofbacilli is the desired
result, concomitant nerve damage is often a serious consequence. Of interest, the
level ofIFN-y and serine esterase gene expression in reversal reaction lesions was
markedly elevated compared with lepromin skin tests and tuberculoid leprosy le-z 0
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(A) Percentages of CD4' subpopulations in leprosy lesions . TheThelper/memory
subpopulations was identified as CD4'UCHLl' orCD4'2H4-; whereas, the Tnaive subpopu-
lation was identified as CD4'2H4' . (B) Percentages ofCD8' subpopulations in leprosy lesions .
TheTcyotoxic subpopulations was identified as CD8'9.3' ; whereas, the Ts subpopulation was
identified as CD8'9.3- .
sions . Since Kaufmann (47) has shownin the mousethat induction ofclass IIMHC
onM . leprae antigen-containing Schwann cells by IFN--y permits them to be killed
in vitro, it is intriguing to speculate that reversal reactions representahyperimmune
DTH response in man in whichT cell cytotoxicity mediates severe nerve damage.
Analysis ofENL lesions revealed clear differences from that of reversal reaction
(Fig . 6) . Although phenotypic Th cellspredominated in ENL lesions, thehigh levels
of IFN--y gene expression, characteristic of reversal reactions, were not observed .
ENL granulomas lacked the characteristic microanatomic separation ofT cell sub-
populations found in tuberculoid and reversal reaction granulomas . In addition,
T cytotoxic cells as measured by 9.3 antigen expression andhuHF serine esterase
gene expression were relatively low in these ENL specimens . The relative absence
of a DTH-like response in ENL correlates with the inability of the immune cells
in these lesions to clear bacilli .
The differences observed betweenreversal reactions andENL reactions in leprosy
can be conceptualized as representing fundamentally different dynamic events oc-
curring in the lesions of the patients . Reversal reactions would appear to reflect a
FIGURE 6 .
￿
Differential increases over background ofvarious T cell subpopulations in reversal
reaction compared with ENL lesions.1578
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selective increase of CD4+ IFN-y producing and CD4+ and/or CD8+ CTL activity
in the lesions, with thenumber of CD8+ Ts cells remaining almost constant. In con-
trast, ENL reactions may be visualized as atransient diminution of Ts activity, leading
to partial augmentation of Th activity. We have reported a transient diminution
of Ts activity in vitro during ENL episodes (24). The diminution of Ts regulation
could account for the augmentation of both cell-mediated immunity and antibody
formation characteristic of ENL reactions. However, ENL reactions would appear
to lack significant numbers of lymphokine-producing cells and fail to exhibit a
significant increase in CTL cells. This picture could lead to the immune complex
disease symptoms associated with reversal reactions. The changes in T cell subsets
and function in these reactional states of leprosy continue to offer new insights into
regulation of cell-mediated immunity in man.
Summary
Analysis of tissue lesions of the major reactional states ofleprosy was undertaken
to studythe immune mechanisms underlying regulation of cell-mediated immunity
and delayed-type hypersensitivity (DTH) in man. In situ hybridization hybridiza-
tion of reversal reaction biopsy specimens for INFy mRNA expression revealed a
10-fold increase in specific mRNA-containing cells over that observed in unrespon-
sive lepromatous patients. Expression of huHF serine esterase, amarker for Tcyto-
toxic cells, were fourfold increasedin reversal reaction and tuberculoidlesionsabove
that detected in unresponsive lepromatousindividuals. Immunohistology ofreversal
reactions confirmed a selective increase of Th and T cytotoxic cells in the cellular
immune response. Of interest, the microanatomic location of these serine esterase
mRNA-containing cells was identical to the distribution of CD4+ cells.
Analysis of erythema nodosum leprosum (ENL) lesions revealed differences in
the underlying immune processes in comparison with reversal reaction lesions. Al-
though phenotypic Th cells predominated in ENLlesions, IFN-y and serine esterase
gene expression were markedly reduced. We suggest that reversal reactions repre-
sent a hyperimmune DTH response characterized by a selective increase of CD4+
IFN-y producing cells and T cytotoxic cells, which result in the clearing of bacilli
and concomitant tissue damage. In contrast, ENL reactions may be viewed as a
transient diminution of Ts cells and activity leading to a partial and transient aug-
mentation in cell-mediated immunity, perhaps sufficient to result in antibody and
immune complex formation, but insufficient to clear bacilli from lesions.
Receivedforpublication 30 November 1988 and in revisedform 12 January 1989.
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